Category: Treatments & Protocols

Peripheral neuropathy treatments for the feet come in two kinds. Some treat the sensation. Others treat whatever is damaging the nerve. Both have a place, but only the second one changes where you end up in five years.

Say the burning, numbness or electric pain sits in both feet. The first question almost everyone asks is what can be done about it.

Most feet-first neuropathy starts with metabolism. Metabolic damage responds to being addressed at the source, not just muffled. That is the core idea behind everything below.

Why does neuropathy start in the feet?

The nerves running to your toes are the longest cells in the body. A single sensory axon (the long wire of a nerve cell) runs from the base of the spine to the sole of the foot on one unbroken supply line. It is fed by the smallest blood vessels in the peripheral nervous system, the vasa nervorum. That combination — the longest distance, the highest fuel demand, the most fragile blood supply — makes the far end of the nerve the first thing to fail when fuel and oxygen delivery falters.

This is why the pattern is so consistent. Symptoms begin in the toes and work upward on both sides evenly. They reach the fingers only later, once the damage has climbed to about knee height. Clinicians call it a length-dependent or “stocking-glove” distribution. It is the fingerprint of a whole-body process, not a local injury.¹ We break that pattern down in peripheral neuropathy of the feet symptoms.

Want to learn more about nerve pain and the treatments we use? Get our neuropathy video series by email.

Can you have neuropathy in your feet without diabetes?

One national sample covered 7,116 U.S. adults aged 40 and older. Peripheral neuropathy was present in 13.5% of them. That was 27.0% of adults with diabetes, but also 11.6% of adults without it. Over a median 13 years of follow-up, neuropathy was independently associated with death from any cause in both groups.²

Read that second figure again. More than one in ten adults with no diabetes diagnosis had measurable loss of feeling in the foot. Losing feeling in your feet is not a harmless nuisance of aging. It is a signal about the state of the blood vessels and metabolism that supply them.

The metabolic terrain, not just the glucose number

Here is the finding that should change how neuropathy is worked up. Researchers properly tested 107 patients in a row with so-called idiopathic neuropathy (neuropathy with no known cause). Of those, 36 — 34% — had impaired glucose tolerance. That is nearly three times the rate in controls of the same age. In many of those patients the fasting glucose and the HbA1c were normal. Only the two-hour oral glucose tolerance test was abnormal.³

A normal A1c does not rule out a glucose-driven neuropathy. It rules out one way of measuring glucose handling.

And glucose is only one lever. Another study looked at 219 patients with idiopathic neuropathy. Some had fully normal blood sugar. They carried just as heavy a load of metabolic syndrome features as those with impaired glucose tolerance. Lipid (blood fat) problems were especially common. The patients had higher total and LDL cholesterol and more abnormal HDL and triglycerides than a comparison group of people who had diabetes but no neuropathy.⁴

Nerves are damaged by the whole metabolic environment acting together. That means glucose, insulin resistance, triglycerides, blood pressure, oxidative stress and the tiny blood vessel supply. That is what we mean by nerve terrain. It is the reason a treatment plan that only adjusts one number tends to stall.

The fibers that fail first in this process are the small ones. That is also why a standard nerve conduction study can read normal while the feet burn every night. That situation is common enough to deserve its own article: small fiber peripheral neuropathy symptoms and testing.

It also fits what we see in our own patients. Fewer than 3% of the people who come to the Padda Institute practice are metabolically healthy by standard criteria. Among those with chronic pain, it is fewer than 1%. Those are practice-reported figures from our own population, not trial outcomes, and individual results vary. But they tell you which direction to look first.

What medications help neuropathy pain in the feet?

Medication for nerve pain is legitimate and often necessary. It should also be described accurately. It changes what you feel, not what is happening to the nerve.

The 2022 American Academy of Neurology guideline pooled the trial evidence for painful diabetic polyneuropathy. It found the major drug classes taken by mouth bunched tightly together. Gabapentinoids showed a standardized mean difference of 0.44. SNRIs showed 0.47, and sodium channel blockers 0.56. SNRI/opioid dual-mechanism agents showed 0.62. All of them sit just above or just below the line for a medium effect size. Tricyclic antidepressants showed a large effect size, but with low confidence in the estimate.⁵

Two practical conclusions follow. First, no oral drug is dramatically better than the others. So the choice should be driven by your other conditions, your sleep, your mood and the side effects you can tolerate. If one class fails, trying a different class is a reasonable next step. Second, the same guideline states that clinicians should not use opioids for painful diabetic neuropathy. That is a formal recommendation, not a preference.

High-concentration topical capsaicin is the one symptom treatment that can plausibly claim to do more than muffle. The 8% patch works by switching off overactive pain fibers (nociceptive fibers) in the skin. There is published evidence of nerve fiber regeneration afterward, alongside the pain relief.⁶ We use it at Regenerve. It is covered in more depth in our article on the high-concentration capsaicin protocol.

Treatments aimed at the cause

Glucose control — necessary, and by itself not sufficient

A Cochrane review of 17 randomized studies found that tighter glucose control clearly prevents clinical neuropathy in type 1 diabetes. The yearly risk difference was −1.84%. In type 2 diabetes the same approach cut new cases of clinical neuropathy. But that did not reach formal statistical significance. It did significantly improve nerve conduction and vibration thresholds (the smallest buzz the feet can feel). Tight control also significantly raised the risk of severe hypoglycemia (dangerously low blood sugar).⁷

This is one of the most useful and least-quoted findings in the field. Most of our patients have type 2 diabetes. In that group, chasing the glucose number alone does not do the job. The lipid, blood pressure, weight and insulin-resistance parts of the terrain have to be treated as part of the neuropathy plan. They are not separate problems that belong to a different doctor.

Diet and exercise, measured at the nerve

Thirty-two patients with impaired glucose tolerance and neuropathy got individualized diet and exercise counseling for one year. They had skin biopsies before and after. Intraepidermal nerve fiber density went up. That is the count of tiny nerve endings in the skin. It rose by 1.4 fibers per millimeter at the proximal site, the spot closer to the trunk. The improvement correlated with reduced nerve pain.⁸

Nerve fibers grew back. Not in an animal model — in people, measured on biopsy, after a year of changing what they ate and how much they moved. This is still one of the strongest arguments for treating the metabolic terrain as the main intervention. It is not the lifestyle advice you give on the way out the door. We cover the training side of this in exercises for peripheral neuropathy in the feet.

Finding the driver that is not metabolic

Not every neuropathy is metabolic, and some of the non-metabolic causes are correctable. Here are the ones worth ruling in or out. One is functional B12 deficiency, which can be present despite a normal B12 level. Another is gluten-related nerve injury, including cases with a negative celiac test. Then there is autoimmune disease, and medications including statins and long-term metformin. There are heavy metals, mold and mycotoxins and alcohol. There is malabsorption after surgery. And there is nerve compression, which can exist alongside a metabolic neuropathy and make it worse. The full account is in the 11 hidden drivers of peripheral neuropathy.

The therapies we add on top

Once the driver is identified, treatment can be aimed at it. At our St. Louis clinic that toolkit includes class 4 photobiomodulation, class 3B cold laser and whole-body infrared. It also includes peripheral and vagal nerve stimulation, nutritional counseling, and balance and gait training. Where protective sensation has been lost, it includes wound care. Orthobiologic injections including PRP and BMAC are also offered. They are used as add-ons inside a plan — never as a substitute for finding the cause. The full list is on our services page, and the reasoning behind the order is in the Regenerve Protocol.

Supplements and complementary approaches

Some have real randomized evidence. Alpha-lipoic acid, acetyl-L-carnitine, palmitoylethanolamide and acupuncture are among them. Some widely sold products have failed when tested properly. We grade them one by one in alternative medicine for peripheral neuropathy.

How do you protect numb feet while you treat them?

When feeling drops below a certain threshold, the foot stops reporting injury. That is what makes neuropathy dangerous, not merely uncomfortable. A 10-gram monofilament test finds loss of protective sensation. Anyone who has it needs daily visual foot checks and properly fitted footwear. They need prompt care for any blister, crack or callus — because the usual warning signal is gone.⁹ Never soak numb feet in water you have not tested with your hand or a thermometer.

Honest expectations

Nerve tissue repairs slowly, and not all damage can be reversed. Progress is measured in less pain, better sleep, steadier balance and better function. That usually takes months, not weeks. Anyone promising a cure for peripheral neuropathy is telling you something that cannot be supported. What can often be changed is the trajectory, especially when an active driver is found and treated.

Being evaluated in St. Louis

Regenerve is at 4477 Woodson Rd #104, St. Louis, MO 63134, minutes from St. Louis Lambert International Airport. It is led by Dr. Gurpreet Singh Padda, MD, MBA, MHP. The practice serves the St. Louis region, Missouri and Illinois. Electrodiagnostic testing is done on site, so the evaluation and the results happen in the same place.

Call (314) 886-5739 or text (314) 886-5902, or email info@regenerve.com. Office hours are Monday through Thursday 9:00 to 16:00 and Friday 9:00 to 13:30. Details are on the contact page and the locations page.

The clearest place to begin is the Nerve Damage Score. It is a five-question assessment that produces a large-print report you can bring to any physician.

Frequently asked questions

What is the best treatment for peripheral neuropathy in the feet?

There is no single best treatment, because the right one depends on what is damaging the nerve. Pain medication, topical capsaicin, metabolic correction and nerve-directed therapies all have a place. The plan should follow the diagnosis, not come before it. See the Regenerve Protocol.

What is the best treatment for diabetic neuropathy in the feet?

There is no single drug that fixes it. In diabetes the nerve damage is driven by the metabolic terrain. So the treatment that changes the nerve is the treatment aimed at that terrain. In studies, nerve fiber density on skin biopsy has risen with that kind of treatment. But that work is measured in months, and no one can promise a cure.

Pain medication is worth having in the meantime, but do not confuse the two. Gabapentinoids, SNRIs and tricyclics treat the pain, not the nerve damage. And the major oral classes bunch tightly together in effect.

The reason the plan cannot stop at glucose is the evidence itself. A Cochrane review of 17 randomized studies found that tighter glucose control clearly prevents clinical neuropathy in type 1 diabetes. In type 2 — the group most of our patients belong to — it reduced new cases without reaching statistical significance. It also significantly raised the risk of severe hypoglycemia. Glucose is one lever, not the whole plan. Lipids, blood pressure, weight and insulin resistance belong in the neuropathy plan. They do not belong to a different doctor. See diabetic peripheral neuropathy treatment in St. Louis.

Can peripheral neuropathy in the feet be reversed?

Not reliably. In one study, diet and exercise counseling in patients with impaired glucose tolerance produced measurable regrowth of nerve fibers on skin biopsy after one year. Not all damage is reversible, and no one can promise a cure. See how sugar damages nerves.

My A1c is normal. Can my neuropathy still be metabolic?

Yes. In one study of patients with idiopathic neuropathy, 34% had impaired glucose tolerance. A normal fasting glucose and normal HbA1c had missed it. Only the two-hour glucose tolerance test revealed it. See how sugar damages nerves.

Should I be taking gabapentin or pregabalin?

They are reasonable options with a modest average effect, close to SNRIs, tricyclics and sodium channel blockers. They treat the pain, not the nerve damage. So they work best alongside treatment aimed at the cause. See the hidden drivers of peripheral neuropathy.

Are opioids used for neuropathy in the feet?

The American Academy of Neurology says not to use opioids for painful diabetic polyneuropathy. Our practice cuts opioid burden instead of adding to it. See which specialist you should see.

How long before treatment helps?

Symptom treatments can work within weeks. Treatment aimed at the underlying metabolic driver takes months, because nerves recover slowly, if they recover at all. See the Regenerve Protocol.

Is it good to walk with neuropathy in your feet?

Movement is part of treating the cause, not just the pain. In one study, people with neuropathy and impaired glucose tolerance got a year of diet and exercise counseling. It regrew nerve fibers in the skin, and their pain dropped as the fibers came back. If your feet are numb, wear properly fitted shoes. Check your feet every day for blisters or cracks. See exercises for peripheral neuropathy in the feet.

Can you die from peripheral neuropathy?

Treat it as a warning sign, not a nuisance. A national study looked at 7,116 U.S. adults aged 40 and older. People with neuropathy were more likely to die of any cause over a median of 13 years, whether or not they had diabetes. Numb feet also stop reporting injuries, so a small blister or crack can go unnoticed. That is why the cause needs to be found, not just the pain muffled.

Do vitamins or natural remedies help neuropathy in the feet?

Some do and some do not. Alpha-lipoic acid, acetyl-L-carnitine, palmitoylethanolamide (PEA) and acupuncture have real randomized evidence. Some widely sold products failed when tested properly. A vitamin can also matter in another way. Functional B12 deficiency is a correctable cause of neuropathy. It can be present even when the B12 blood level looks normal. See alternative medicine for peripheral neuropathy.

Sources

1. Tesfaye S, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010. PMID 20876709
2. Hicks CW, Wang D, Matsushita K, Windham BG, Selvin E. Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults: A Prospective Cohort Study. Annals of Internal Medicine. 2021. PMID 33284680
3. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care. 2001. PMID 11473085
4. Smith AG, Rose K, Singleton JR. Idiopathic neuropathy patients are at high risk for metabolic syndrome. Journal of the Neurological Sciences. 2008. PMID 18606421
5. Price R, et al. Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary. Neurology. 2022. PMID 34965987
6. Anand P, et al. Reversing painful and non-painful diabetic neuropathy with the capsaicin 8% patch: clinical evidence for pain relief and restoration of function via nerve fiber regeneration. Frontiers in Neurology. 2022. PMID 36388188
7. Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database of Systematic Reviews. 2012. PMID 22696371
8. Smith AG, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006. PMID 16732011
9. Boulton AJM, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association. Diabetes Care. 2008. PMID 18663232

The alternative treatment for peripheral neuropathy with the strongest evidence is not a supplement. It is diet and exercise aimed at the metabolic terrain. That approach improves nerve fiber density on skin biopsy. Other options have real but more limited support. They are intravenous alpha-lipoic acid, acetyl-L-carnitine, palmitoylethanolamide (PEA), acupuncture and high-concentration capsaicin.

People look for alternative treatments for peripheral neuropathy for a fair reason. The standard drugs treat the pain, not the nerve, and their average effect is modest. That is a real gap, and it is worth filling. It is also the gap the supplement industry has filled with a lot of confident marketing and very little published data.

What follows grades the non-drug options by the evidence that actually exists. It shows what has randomized trial support and what has weak support. It shows what failed when properly tested. And it shows the one approach that beats every bottle on the shelf.

Start with what the label “alternative” is hiding

Most people searching for alternative medicine for neuropathy have already been told nothing can be done about the cause. In a large share of cases that is not true. The cause simply was not looked for hard enough.

One study looked at 107 patients whose neuropathy had been called idiopathic (no known cause). Of these, 34% had impaired glucose tolerance, close to three times the rate in matched controls. In many of them, fasting glucose and HbA1c were normal. Only a two-hour oral glucose tolerance test found it.¹ A separate series looked at 219 idiopathic neuropathy patients. Even those with fully normal blood sugar carried a heavy load of metabolic syndrome features. Lipid (blood fat) problems were especially common.²

So before spending money on supplements, make sure the workup was complete. It should include an OGTT, a full lipid panel, B12 with methylmalonic acid, thyroid studies, and a review of medications. The 11 hidden drivers of peripheral neuropathy covers the rest of that list. Did your nerve conduction study come back normal while your feet still burn? Then read small fiber peripheral neuropathy symptoms and testing before deciding that nothing was found.

What natural treatment has the strongest evidence for neuropathy?

Diet and exercise aimed at the metabolic terrain has better evidence than anything sold as a nerve supplement. And it is measured at the nerve, not on a questionnaire.

Thirty-two patients with impaired glucose tolerance and neuropathy got personalized diet and exercise counseling for one year. They had skin biopsies at the start and at 12 months. Intraepidermal nerve fiber density (nerve fibers in the skin) improved by 1.4 fibers per millimeter at the proximal site, higher on the leg. That gain tracked with less nerve pain.³ A separate study ran a 10-week supervised aerobic and resistance program. The patients had diagnosed diabetic peripheral neuropathy. It produced significant reductions in pain and nerve symptoms. Biopsies also showed more intraepidermal nerve fiber branching.⁴

A 2022 systematic review with meta-analysis pooled 41 randomized controlled trials. It found the evidence now supports a specific plan for diabetic peripheral neuropathy. The plan mixes endurance training with sensorimotor (balance) training. It helped balance measures and functional mobility. It helped peroneal and sural nerve conduction velocity. It also helped HbA1c.⁵

Nothing in the supplement aisle has that level of support. The practical program is in exercises for peripheral neuropathy in the feet.

Alpha-lipoic acid: real evidence, with an important qualifier

Alpha-lipoic acid is an antioxidant. It is the best-studied supplement in this field. A meta-analysis pooled four randomized, double-blind, placebo-controlled trials: ALADIN I, ALADIN III, SYDNEY and NATHAN II. Together they had 1,258 patients. After three weeks, the Total Symptom Score in the feet showed a 24.1% relative improvement versus placebo. Responder rates were 52.7% on alpha-lipoic acid against 36.9% on placebo. Pain, burning and numbness all improved. So did pinprick and touch-pressure feeling and ankle reflexes. Adverse event rates did not differ.⁶

The catch matters: that evidence is for 600 mg given intravenously, daily for three weeks. The oral capsules sold over the counter are not the same treatment, and their evidence is much weaker. If someone recommends a supplement based on “the ALADIN trials,” ask whether the study used the oral form.

Acetyl-L-carnitine: modest, in a specific population

Acetyl-L-carnitine improved pain, vibratory perception and measures of nerve regeneration in patients with chronic diabetic neuropathy in randomized trial data, with the clearest effect in those treated earlier in the disease course.⁷ It is a reasonable adjunct with a real, if modest, evidence base. It is not a substitute for treating the driver.

Palmitoylethanolamide: promising, and worth reading carefully

Palmitoylethanolamide, or PEA, is a naturally occurring fatty acid amide. A systematic review and meta-analysis pooled 11 double-blind randomized controlled trials. They covered 774 patients with chronic pain. Pain scores fell compared with the alternatives tested. No study tied major side effects to PEA.⁸ The authors noted that the best dose and delivery still need to be worked out. The trials also covered chronic pain in general, not neuropathy alone.

PEA is one of the supportive agents we use at our St. Louis clinic. We use it within a plan, not as a standalone answer.

Acupuncture: low-certainty evidence, genuine effect size

A 2025 systematic review and meta-analysis pooled 14 randomized trials. They had 1,169 participants. Compared with sham, acupuncture may cut pain in diabetic peripheral neuropathy by 1.44 cm on a 10 cm pain scale (visual analog scale). It may also reduce overall neurologic symptom severity. Adverse events showed little to no difference. The authors graded the certainty of that evidence as low.⁹

Low certainty does not mean it does not work. It means the trials were small or at risk of bias, and the estimate could move. Given how safe it is, acupuncture is a sound thing to try alongside treatment aimed at the cause.

Does capsaicin help neuropathy pain in the feet?

High-concentration capsaicin at 8% is a prescription patch, not a store-bought cream. People often find it while searching for natural options, because capsaicin comes from chili peppers. It works by switching off overactive pain fibers (nociceptive fibers) in the skin. There is published evidence of later nerve fiber regeneration along with the pain relief.¹⁰ We use it, and it is covered in the high-concentration capsaicin protocol.

Light-based therapies: mechanistic rationale, thin trial evidence

Photobiomodulation targets cytochrome c oxidase. That is an enzyme in the mitochondria, the cell’s power plants. It is meant to support energy production and blood flow in injured nerve tissue. We offer class 4 photobiomodulation, class 3B cold laser and whole-body infrared at the clinic. They are described on the services page.

Here is the honest state of the evidence. The reasoning behind how it works holds together. But the randomized trial base for diabetic peripheral neuropathy is still limited. Several systematic reviews have been registered and published only as protocols, not finished reviews. We use these therapies as add-ons within a plan built on finding and treating the cause. We do not present them as the treatment.

Which neuropathy supplements have failed in trials?

This section matters as much as the others. Benfotiamine is a fat-soluble form of thiamine (vitamin B1). It is sold widely for neuropathy. It was tested in a 12-month randomized, placebo-controlled, double-blind trial. The patients had type 2 diabetes and symptomatic polyneuropathy. It raised blood levels of all six thiamine analytes (markers) measured. That confirmed it was absorbed and doing something chemically in the body. But it had no significant effect on corneal nerve fiber length. It had no significant effect on the secondary morphometric, functional and clinical neuropathy outcomes. And it had no significant effect on quality of life.¹¹

That is what a well-run negative trial looks like, and it is a useful yardstick. Ask this of any product sold for neuropathy: has it been tested this way, and what happened?

Which neuropathy treatments should you be skeptical of?

• Any product or program promising to cure, reverse or eliminate neuropathy. Nerve recovery is partial and slow, and it depends on the cause. A cure claim is a marketing claim.
• Proprietary “nerve support” blends that mix a dozen ingredients at doses below those used in any trial. No single ingredient reaches a studied dose.
• Fixed packages of sessions sold before a diagnosis. The number of treatments should follow clinical need and response, not a package bought in advance.
• High-dose vitamin B6. Excess B6 causes a sensory neuropathy in its own right. More is not better here.
• Anything that requires stopping your prescribed medication to work.

How we think about this

To us, alternative and complementary approaches are not a separate kind of medicine. They are treatments with an evidence base, to be graded like any other. Where the evidence supports something, we use it. Where it does not, we say so. And none of it replaces finding what is damaging the nerve. That order of steps is set out in the Regenerve Protocol. The full range of treatments is in peripheral neuropathy treatments for the feet.

Talk to your physician before starting any supplement. This matters most if you take anticoagulants (blood thinners), thyroid drugs or diabetes drugs. Note that alpha-lipoic acid can lower blood glucose.

Being evaluated in St. Louis

Regenerve is at 4477 Woodson Rd #104, St. Louis, MO 63134, minutes from St. Louis Lambert International Airport, and is led by Dr. Gurpreet Singh Padda, MD, MBA, MHP. The practice serves the St. Louis region, Missouri and Illinois. Electrodiagnostic testing is performed on site.

Call (314) 886-5739 or text (314) 886-5902, or email info@regenerve.com. Office hours are Monday through Thursday 9:00 to 16:00 and Friday 9:00 to 13:30. Details are on the contact page and the locations page.

Before buying anything, take the Nerve Damage Score. It is a five-question assessment that gives you a large-print report you can bring to any physician.

Alpha-lipoic acid has the most trial data of the supplements discussed here. The details are in alpha-lipoic acid for peripheral neuropathy: what the trials show.

Frequently asked questions

What is the best alternative treatment for peripheral neuropathy?

Diet and exercise aimed at the metabolic terrain has the strongest evidence, including measured regrowth of nerve fibers on skin biopsy. No supplement matches it. See exercises for peripheral neuropathy in the feet.

Does alpha-lipoic acid work for neuropathy?

The strong trial evidence is for 600 mg given intravenously over three weeks. That produced a 24.1% relative improvement in symptom scores versus placebo. Evidence for over-the-counter oral capsules is much weaker. See how sugar damages nerves.

Does acupuncture help neuropathy in the feet?

A meta-analysis of 14 randomized trials looked at acupuncture versus sham. It found acupuncture may reduce pain and neurologic symptom severity, with few adverse events. The certainty of that evidence was low. See peripheral neuropathy treatments for the feet.

Should I take benfotiamine for neuropathy?

A 12-month randomized placebo-controlled trial tested benfotiamine. It raised thiamine levels. But it had no significant effect on nerve structure, nerve function, clinical neuropathy measures or quality of life. See functional B12 deficiency and neuropathy.

Are supplements enough on their own?

No. Supplements address one input at a time. Neuropathy is driven by the whole metabolic environment. It is also driven by any nutritional, autoimmune, toxic or structural driver that is present. See the hidden drivers of peripheral neuropathy.

Can vitamins make neuropathy worse?

Yes. High-dose vitamin B6 can cause a sensory neuropathy of its own. So taking it without knowing your levels can add a driver instead of removing one. See functional B12 deficiency and neuropathy.

What is the number one supplement for neuropathy?

Alpha-lipoic acid is the best studied. But the strong results come from 600 mg given intravenously each day for three weeks, not from over-the-counter capsules. Acetyl-L-carnitine and palmitoylethanolamide (PEA) have real but more modest support. None of them matches diet and exercise aimed at the metabolic terrain. In studies, that approach has increased nerve fiber density measured on skin biopsy.

What exercises help neuropathy in the feet?

A 2022 review looked at 41 randomized trials in diabetic peripheral neuropathy. It supports combining endurance training with sensorimotor, or balance, training. That mix improved balance, functional mobility, nerve conduction velocity and HbA1c. A separate 10-week program used supervised aerobic and resistance training. Pain and nerve symptoms dropped. See exercises for peripheral neuropathy in the feet.

Does red light or laser therapy help neuropathy?

The reasoning behind it is sound, but the trial evidence is still thin. Photobiomodulation targets an enzyme in the mitochondria. The goal is to support energy production and blood flow in injured nerve tissue. Yet the randomized trial base for diabetic peripheral neuropathy remains limited. We offer class 4 photobiomodulation, class 3B cold laser and whole-body infrared as add-ons. They sit within a plan that treats the cause. They are not the treatment itself.

Is PEA safe to take for nerve pain?

One review pooled 11 double-blind randomized trials covering 774 people with chronic pain. No study tied major side effects to palmitoylethanolamide (PEA). Pain scores fell compared with the alternatives tested. The best dose is still not settled. And those trials covered chronic pain in general, not neuropathy alone. Talk to your physician before starting any supplement.

Sources

1. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care. 2001. PMID 11473085
2. Smith AG, Rose K, Singleton JR. Idiopathic neuropathy patients are at high risk for metabolic syndrome. Journal of the Neurological Sciences. 2008. PMID 18606421
3. Smith AG, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006. PMID 16732011
4. Kluding PM, et al. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. Journal of Diabetes and its Complications. 2012. PMID 22717465
5. Streckmann F, et al. Exercise and Neuropathy: Systematic Review with Meta-Analysis. Sports Medicine. 2022. PMID 34964950
6. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabetic Medicine. 2004. PMID 14984445
7. Sima AAF, et al. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy. Diabetes Care. 2005. PMID 15616239
8. Lang-Illievich K, et al. Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients. 2023. PMID 36986081
9. Lan L, et al. Acupuncture for the Management of Chronic Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Current Pain and Headache Reports. 2025. PMID 40220243
10. Anand P, et al. Reversing painful and non-painful diabetic neuropathy with the capsaicin 8% patch: clinical evidence for pain relief and restoration of function via nerve fiber regeneration. Frontiers in Neurology. 2022. PMID 36388188
11. Ziegler D, et al. Effects of benfotiamine treatment over 12 months on morphometric, neurophysiological and clinical measures in type 2 diabetes patients with symptomatic polyneuropathy (BOND study). BMJ Open Diabetes Research & Care. 2026. PMID 41571333

The exercises that work for peripheral neuropathy in the feet combine endurance and sensorimotor balance training. Add strength work two to three days a week and five minutes of foot and ankle mobility daily.

Exercise is the only treatment for peripheral neuropathy in the feet that has been shown, in people and not just animals, to change the nerve fibers themselves. Yet it is usually mentioned last, on the way out the door.

This article sets out what the trials actually tested and why it works. It gives a practical weekly program you can start with. And it covers the foot-protection rules that make exercising on numb feet safe.

Does exercise help peripheral neuropathy in the feet?

A 2022 systematic review with meta-analysis pooled 41 randomized controlled trials of exercise in patients with neuropathy. Of those, 27 were in diabetic peripheral neuropathy. The authors concluded that evidence-based advice can now be given for this group. They found the most helpful approach is a combination of endurance and sensorimotor training. Effects favored exercise across static balance, the Berg Balance Scale, the Timed Up and Go test, peroneal and sural nerve conduction velocity, and HbA1c.¹

Look at what is in that list. The point is more than “patients felt better” here. Nerve conduction velocity and HbA1c both moved. Exercise is acting on the nerve and on the metabolic environment that damaged it.

Two smaller studies show the same thing at the level of the nerve fiber. In one, 17 people with diagnosed diabetic peripheral neuropathy did a 10-week supervised aerobic and strength program. It produced significant reductions in pain and in nerve symptoms. Skin biopsies also showed more intraepidermal nerve fiber branching.² In the other, 32 patients with impaired glucose tolerance and neuropathy got a year of diet and exercise counseling made for each person. Their intraepidermal nerve fiber density rose by 1.4 fibers per millimeter at the biopsy site higher up the leg. That gain tracked with less nerve pain.³

These were small studies without large control groups, and they are not a promise of recovery. But they are direct evidence that nerve fibers respond to a change in the metabolic environment.

Why does exercise help neuropathy?

The nerves to your toes are the longest cells in the body, and they are fed by the smallest blood vessels. They fail first when fuel and oxygen delivery falters. Exercise attacks that problem from several sides at once. It improves insulin sensitivity and sugar handling. It lowers triglycerides and raises HDL. It improves tiny-vessel function and increases blood flow to the vasa nervorum, the vessels that feed the nerve itself.

That breadth is exactly what this condition needs. Tighter sugar control alone has a clear preventive effect in type 1 diabetes. But the effect is much weaker in type 2, where blood fats, blood pressure and insulin resistance carry a lot of weight.⁴ Among patients with idiopathic neuropathy, even those with fully normal blood sugar carried a heavy load of metabolic syndrome features, especially abnormal blood fats.⁵ Exercise is one of the few treatments that moves all of those at once. The mechanism is covered further in how sugar damages nerves.

How do you exercise safely with neuropathy in your feet?

• Get cleared. Talk to your physician first. This matters most if you have heart disease, eye disease from diabetes (retinopathy), kidney disease, an open wound, or an unexplained hot, swollen foot. A hot, swollen foot needs a checkup before any weight-bearing exercise.
• Inspect both feet before and after every session, including between the toes and the soles. Use a mirror if you cannot see them easily. When protective feeling is dulled, the foot stops reporting injury. That is why the visual check replaces the pain you would normally feel.⁶
• Wear properly fitted athletic shoes and seamless socks. Check inside the shoe with your hand before putting it on.
• Have support available. Do balance work next to a counter, a wall or a sturdy chair.
• Stop for any new blister, hot spot, unusual swelling, chest symptoms or a fall.

What is a good weekly exercise plan for neuropathy?

The evidence points to endurance plus sensorimotor training, with strength work supporting both. Build up to this over four to six weeks instead of starting at the top.

1. Endurance — 3 to 5 days per week

Start with 10 minutes and add 2 to 3 minutes per week. Work toward 30 minutes at a pace where you can talk but not sing. Walking is the default. Foot pain, ulcer risk or poor balance may make walking unwise. If so, a stationary bike, a recumbent bike, a rowing machine, an arm ergometer or water walking gives the same metabolic benefit while taking weight off the foot.

2. Sensorimotor and balance work — 3 to 5 days per week, 10 to 15 minutes

This is the part the meta-analysis found most crucial, and it is the one people skip. Always work within reach of a support.

• Feet-together stand — 30 seconds, progressing to eyes closed once it is easy with eyes open
• Semi-tandem then tandem stand — one foot partly, then fully in front of the other, 20 to 30 seconds each side
• Single-leg stand — start at 5 to 10 seconds per side, build toward 30
• Heel-to-toe walking — 10 steps along a countertop
• Weight shifts — forward, back and side to side, slowly, feeling the pressure move across the foot
• Head turns while standing — a harder test that trains the inner ear’s part in balance
• Foam or cushion standing — only once firm-ground work is reliably steady

Make it harder by taking away support, not by adding time. Go from eyes open to eyes closed, from two hands on the counter to one finger to none, and from firm ground to a soft surface.

3. Resistance — 2 to 3 days per week, non-consecutive

Do two to three sets of 10 to 15 reps of a few multi-joint moves. Good ones are sit-to-stand from a chair, heel raises, a seated or standing leg press or wall squat, hamstring curls, hip abduction, and rows or presses for the upper body. Elastic-band strength training has been studied in older adults with diabetic peripheral neuropathy for its effect on balance and fear of falling. It needs no equipment beyond a band.⁷

4. Foot and ankle mobility — daily, 5 minutes

• Ankle pumps, circles, and alphabet tracing with the toes
• Toe curls and spreads, and picking up a towel with the toes
• Calf and Achilles stretches — 30 seconds each side, twice
• Seated rolling of the sole over a ball, gently, and never on numb skin you have not inspected

5. Interrupt the sitting

Stand and move for two to three minutes every 30 minutes. This is not filler. Long stretches of sitting worsen sugar handling, whether or not you exercised earlier that day. And sugar handling is the thing you are trying to change.

What to expect, and when

Balance and steadiness usually improve first, often within four to six weeks. That is because they depend partly on training the feeling you still have and the muscles that use it. Pain and burning tend to shift over two to three months. Changes at the level of nerve fibers were measured at 10 weeks in one study and at 12 months in the other. This is a long-term treatment.

Some people notice a short-lived rise in feeling or discomfort in the first weeks. That usually settles. Sharp new pain, a hot or swollen foot, or any open area means stop and be seen.

Exercise is not the whole plan

Exercise is the highest-payoff thing you can do yourself. It does not replace finding out what is damaging the nerve. The cause may be a B12 deficiency, gluten-related injury, a medication, a toxic exposure or nerve compression. If so, that needs to be treated directly. The full list is in the 11 hidden drivers of peripheral neuropathy. How exercise fits alongside medical treatment is in peripheral neuropathy treatments for the feet. The supplements people usually ask about next are graded in alternative medicine for peripheral neuropathy.

Being evaluated in St. Louis

Regenerve is at 4477 Woodson Rd #104, St. Louis, MO 63134, minutes from St. Louis Lambert International Airport, and is led by Dr. Gurpreet Singh Padda, MD, MBA, MHP. The practice serves the St. Louis region, Missouri and Illinois. Balance and gait training, physical rehabilitation and nutritional counseling are part of what we offer, and electrodiagnostic testing is performed on site. The full list is on the services page.

Call (314) 886-5739 or text (314) 886-5902, or email info@regenerve.com. Office hours are Monday through Thursday 9:00 to 16:00 and Friday 9:00 to 13:30. Details are on the contact page and the locations page.

If you are not sure how far your neuropathy has progressed, the Nerve Damage Score can help. It is a five-question check that gives you a large-print report you can bring to any physician.

Frequently asked questions

What are the best exercises for peripheral neuropathy in the feet?

A combination of endurance training and sensorimotor or balance training, backed by strength work. A meta-analysis of 41 randomized trials found that combination most helpful in diabetic peripheral neuropathy. See peripheral neuropathy treatments for the feet.

Is walking safe if my feet are numb?

Usually yes, with well-fitted shoes and a look at both feet before and after every session, because a numb foot no longer reports injury. Any open wound or a hot, swollen foot needs a checkup before weight-bearing exercise. See peripheral neuropathy of the feet symptoms.

Can exercise regrow damaged nerves?

There is evidence that it can contribute. A 10-week supervised exercise program increased intraepidermal nerve fiber branching on skin biopsy. A year of diet and exercise counseling increased nerve fiber density. Recovery is partial and slow, and no one can promise a cure. See small fiber neuropathy symptoms and testing.

How long until exercise helps my neuropathy?

Balance and steadiness often improve within four to six weeks. Pain and burning usually shift over two to three months. In the published studies, changes measured at the nerve fiber were seen at 10 weeks and at 12 months. See the Regenerve Protocol.

What if I cannot walk far or my balance is poor?

Use a seated or supported option for the endurance part, such as a recumbent bike, an arm ergometer or water walking. Do balance work holding a counter. The metabolic benefit does not require walking. See the hidden drivers of peripheral neuropathy.

Should I exercise if it makes my feet hurt more?

A short-lived rise in feeling in the first weeks is common and usually settles. Sharp new pain, a new blister or hot spot, or a hot and swollen foot means stop and get checked. See which specialist you should see.

Does wiggling your toes help neuropathy?

Toe movement is useful, but it is not the main event. Toe curls and spreads, picking up a towel with your toes, and ankle pumps and circles make up a five-minute daily mobility routine. The trial evidence for less pain and better nerve measures comes from endurance plus balance training, backed by strength work. So toe exercises belong alongside that program, not in place of it.

Which exercises should you avoid with neuropathy in your feet?

It depends on your feet. Foot pain, ulcer risk or poor balance may make walking unwise. If so, switch to a stationary or recumbent bike, a rowing machine, an arm ergometer or water walking. Skip weight-bearing exercise until an open wound or a hot, swollen foot has been checked. Save foam or cushion balance work until you are reliably steady on firm ground.

Can I do neuropathy exercises at home?

Most of the program needs no gym. Balance work is done beside a kitchen counter, a wall or a sturdy chair. Strength work can be sit-to-stands from a chair, heel raises and wall squats. Elastic-band training has been studied in older adults with diabetic neuropathy using nothing but a band. Check both feet before and after every session.

Sources

1. Streckmann F, et al. Exercise and Neuropathy: Systematic Review with Meta-Analysis. Sports Medicine. 2022. PMID 34964950
2. Kluding PM, et al. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. Journal of Diabetes and its Complications. 2012. PMID 22717465
3. Smith AG, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006. PMID 16732011
4. Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database of Systematic Reviews. 2012. PMID 22696371
5. Smith AG, Rose K, Singleton JR. Idiopathic neuropathy patients are at high risk for metabolic syndrome. Journal of the Neurological Sciences. 2008. PMID 18606421
6. Boulton AJM, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association. Diabetes Care. 2008. PMID 18663232
7. Armat MR, et al. The Effect of Resistance Exercises Using an Elastic Band on Balance and Fear of Falling in Older Adults With Diabetic Peripheral Neuropathy. Archives of Physical Medicine and Rehabilitation. 2024. PMID 38218307

The Regenerve protocol for peripheral neuropathy starts from a different premise than the standard script. Burning, tingling, and numbness are not the disease. They are the alarm. The goal of treatment is to repair the terrain the nerves live in, not just to mute the signal they are sending.

If you live with peripheral neuropathy, you already know that standard script. You get a prescription for gabapentin or pregabalin and a suggestion to control your blood sugar. Then you get a shrug when neither one gives your feet back to you. This article walks through the logic of that protocol and the science behind each stage. It also gives an honest account of what is established and what is less certain.

Why doesn’t nerve pain medication stop neuropathy from getting worse?

Most people are handed one of two drug types. One is the gabapentinoids (gabapentin, pregabalin). The other is certain antidepressants (duloxetine, amitriptyline). These drugs work by turning down pain signals in the nervous system. They are legitimate tools, and for many patients they take the edge off. But two facts are rarely explained at the pharmacy counter.

First, the benefit is often partial. Across the nerve-pain research, only a minority of patients get substantial (50% or greater) pain relief from any single drug taken by mouth. Many stop because of side effects like sleepiness, dizziness, weight gain, and mental fog. Second — and more important — none of these drugs touch the process that is damaging the nerve. They quiet the alarm while the fire keeps burning. That is why patients so often describe climbing to the top dose and still waking at 3 a.m. with their feet on fire.

The Regenerve premise is that lasting change requires addressing why the nerve is failing. Then you give it the conditions to recover.

Metabolic sovereignty: treating the terrain, not just the nerve

Dr. Gurpreet Singh Padda, MD, MBA, MHP, uses the phrase “metabolic sovereignty” to describe the core idea: your nerves cannot heal in a hostile environment. A nerve fiber is one of the most energy-hungry structures in the body. It must hold an electrical charge along its entire length. It must ship nutrients and mitochondria from the cell body out to the nerve endings. And it must keep repairing its insulating coat, the myelin. Starve it of oxygen, poison it with the byproducts of high blood sugar, or drain its energy supply, and it will misfire, pull back, and finally die back. That starts at the longest, most distant fibers, which is why symptoms begin in the toes and feet.

So before any regenerative step makes sense, the terrain has to be assessed and corrected: blood sugar and glycation, micronutrient status, circulation, inflammatory drivers, and mechanical contributors. This is the diagnostic backbone that a companion article — “The 11 Hidden Drivers Your Doctor Missed” — explores in depth. The protocol below assumes that this root-cause work is happening in parallel; the regenerative tools are not a substitute for it.

Stage one: can a capsaicin patch calm an overfiring nerve?

A damaged nerve can get stuck on high alert (chronically hyperexcitable). Then it fires pain even when there is no real threat. One way to interrupt that is to “defunctionalize” the overactive pain fibers at the skin level using high-concentration capsaicin.

The 8% capsaicin patch (marketed as Qutenza) is the most evidence-backed piece of this stage. It works on the TRPV1 receptor — the same receptor that makes chili peppers feel hot. That receptor sits on the small pain-sensing C-fibers in the skin. A single controlled application first overstimulates those endings. It then reversibly “switches off” those endings, cutting their pain signaling for weeks to months. This is not folk medicine. The U.S. FDA approved the 8% capsaicin patch for postherpetic neuralgia in 2009. After the pivotal STEP trial led by Dr. David Simpson, it approved it for painful diabetic peripheral neuropathy of the feet in 2020. In the controlled data, one 30-minute treatment led to modest but statistically significant drops in daily pain. The main side effect was temporary burning where it was applied. And — importantly — patients did not lose any ability to sense sharp, warm, cold, or vibration stimuli. A separate 52-week safety study (PACE) backed repeated treatment with no harm to function and no neurological (nerve) harm.

An honest caveat belongs here, because this is where marketing often overreaches. The established benefit of capsaicin is pain relief, not proven nerve regrowth. Can repeated capsaicin treatment help damaged nerve fibers actually regenerate? That is a real science question now under formal study. One example is a randomized disease-modification trial out of Cambridge. It is not a settled fact. Regenerve uses capsaicin to open a window. In it, there is less pain and less overactivity in the pain-sensing nerves (nociceptors). In that window, the repair-focused steps have room to work.

Stage two: can PRP or bone marrow concentrate support nerve repair?

Once the fire is calmer and the terrain is being corrected, the protocol turns to helping the tissue rebuild. This is where orthobiologics come in. These are biological materials meant to deliver growth factors and signaling molecules to injured tissue. In the Regenerve protocol they include platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC). Both come from the patient’s own blood or marrow.

The reasoning rests on real biology. Platelets are packed with growth factors. They include nerve growth factor and brain-derived neurotrophic factor. They also include vascular endothelial growth factor and platelet-derived growth factor. They direct healing and angiogenesis (growth of new blood vessels). In laboratory and animal models, they also direct peripheral nerve regeneration. BMAC also supplies a group of mesenchymal cells that can modulate (adjust) inflammation.

Here honesty is essential, and Regenerve’s material is careful about it. PRP and BMAC for peripheral nerve repair are offered as part of an individualized plan. The strongest evidence so far comes from preclinical models and small clinical series, not large randomized trials. Told honestly, they are a treatment made from the patient’s own body and based on how tissue heals. They show encouraging early signals, and the evidence is incomplete. That is exactly why they belong in a doctor-directed plan built for each person, with realistic expectations. They are not a one-size-fits-all promise.

Stage three: why do damaged nerves need working mitochondria?

Even a nerve that is whole cannot work if its mitochondria are failing. Mitochondria are the power plants inside each cell. Chronic hyperglycemia (long-term high blood sugar), toxins, and low nutrients all end in the same place: mitochondria that fail (mitochondrial dysfunction). Dr. Michael Brownlee’s landmark work found one common thread behind the tissue damage of diabetes. It is overproduction of mitochondrial superoxide, a harmful form of oxygen. Repairing the wiring without restoring the power supply leaves the job half done.

So the protocol includes mitochondrial support. At one end is well-established replacement of the helper nutrients (cofactors) nerves depend on. These include the B vitamins, alpha-lipoic acid, and CoQ10. At the other end are more advanced, targeted agents. SS-31 (elamipretide) is a mitochondria-targeted peptide. It is designed to steady cardiolipin, a fat in the inner mitochondrial membrane, and to improve energy production. It is a real compound under active study. This layer of support mixes proven nutrition science with newer targeted tools, chosen case by case.

Why sequence matters

The order is deliberate. Correcting the terrain first means the body is no longer actively re-injuring the nerve. Calming the overfiring pain fibers next opens a period of less pain and less chaos in the pain-sensing nerves. Repair signals and restored mitochondrial energy come last. They give the nerve both the instructions and the fuel to recover during that window. Reverse the order — try to “regenerate” a nerve that is still being starved and glycated every day — and you are building on sand.

How long does peripheral neuropathy treatment take to work?

Peripheral nerves repair slowly, about a millimeter a day at best. So this is a months-long process measured in gradual change, not an overnight fix. A realistic plan begins with evaluation and testing to map which drivers are active. It sets expectations honestly and adjusts over time based on response. Some patients see meaningful improvement. Results vary by person and by how advanced the nerve loss is at the start. The earlier the terrain is corrected, the more nerve there is to save.

Frequently asked questions

Key takeaways

• Standard drugs mute the pain signal but do not repair the nerve. Partial relief and side effects are common.
• The Regenerve protocol treats the terrain first. Then it calms overfiring nerves. Then it supports structural and mitochondrial repair.
• The 8% capsaicin patch is FDA-approved for painful diabetic neuropathy of the feet. It gives real, if modest, pain relief. Nerve-regrowth claims are still under study.
• Orthobiologics (PRP, BMAC) and mitochondrial peptides (SS-31) make sense in biology. They belong in a plan built for each person (an individualized plan).
• Nerve repair is slow. Acting early saves more function.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change any medication or treatment without consulting your physician. Ready to start? Take the free Nerve Damage Score or call (314) 886-5739 or text (314) 886-5902.

References

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–820.
2. Simpson DM, Robinson-Papp J, Van J, et al. Capsaicin 8% patch in painful diabetic peripheral neuropathy: a randomized, double-blind, placebo-controlled study (STEP). J Pain. 2017;18(1):42–53.
3. U.S. FDA. Qutenza (capsaicin) 8% topical system — approval for neuropathic pain associated with diabetic peripheral neuropathy of the feet. 2020.
4. Vinik AI, et al. Capsaicin 8% patch repeat treatment plus standard of care in painful diabetic peripheral neuropathy: 52-week open-label safety study (PACE). BMC Neurol. 2016;16:251.
5. Anand P, Bley K. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the 8% capsaicin patch. Br J Anaesth. 2011;107(4):490–502.
6. Sánchez M, et al. Platelet-rich plasma and peripheral nerve regeneration (review of preclinical and early clinical evidence).
7. Szeto HH. First-in-class cardiolipin-protective compound (SS-31/elamipretide) as a therapeutic agent for mitochondrial dysfunction. Br J Pharmacol. 2014.

The high-strength 8% capsaicin patch works on nerve pain in the feet by switching off the overactive pain fibers in the skin for a while. That process is called defunctionalization. It is FDA-approved, non-opioid and works only where it is applied. It goes on in a doctor’s office in under an hour.

Yet many patients with burning feet have never been offered it. This article explains how it works and what the clinical evidence really shows. It covers why it often takes more than one treatment to see the full benefit, and how it fits into a repair-focused plan. It also draws a careful line between what is proven and what is still being studied. That line is exactly what “mainstream medicine missed” talk tends to blur.

A note on numbers, up front

You may have seen a very high success figure tied to this protocol. To be honest about it: the controlled clinical trials of the 8% capsaicin patch show modest but statistically significant pain relief, not a near-total cure. A higher real-world success rate reported by one clinic reflects that clinic’s own patients, protocol, and definition of success. It is a practice observation, not a figure from the randomized trials, and it should be read that way. What follows sticks to the published science. Then it explains where clinical experience goes beyond it.

How does capsaicin work on nerve pain?

Capsaicin is the compound that gives chili peppers their heat. It acts on a specific sensor on pain-sensing nerve endings called the TRPV1 receptor (transient receptor potential vanilloid 1). TRPV1 is the same sensor that responds to painful heat. That is why capsaicin truly feels hot.

Low-dose capsaicin creams (0.025–0.075%) sold over the counter give mild, short relief. You have to apply them several times a day. The prescription 8% patch is in a different league. It is about a hundred times stronger. It is built to do something the creams cannot: defunctionalize the overactive pain fibers for a while.

Defunctionalization: turning down an alarm that won’t stop

In long-term neuropathy, the small C-fibers in the skin become overexcited. They fire pain signals nonstop, even with nothing touching them. The alarm is stuck on. A single, controlled 30-minute application of the 8% patch delivers enough capsaicin to overload those TRPV1 nerve endings. Then it quiets them, and the effect wears off in time. The nerve endings pull back and stop sending their runaway pain signals. Over the next weeks and months they slowly recover. Most important, controlled studies found this happens without degrading normal sensation. Patients could still feel sharp, warm, cold, and vibration.

The treatment goes on the skin and does not travel through the body. So it avoids the sleepiness, dizziness, and brain fog that limit nerve-pain pills. The main side effect is short-lived burning and redness where the patch sits. That is why it is applied in the clinic, often with skin pre-treatment for comfort.

Is the capsaicin 8% patch FDA-approved, and does it work?

The 8% patch first won FDA approval in 2009 for postherpetic neuralgia (the nerve pain that lingers after shingles). In 2020, based on the key STEP trial led by Dr. David Simpson, the FDA widened approval to painful diabetic peripheral neuropathy of the feet. In STEP, a single 30-minute treatment gave a statistically significant drop in average daily pain compared with placebo. A separate 52-week study (PACE) showed that repeated treatments were well tolerated over a full year. Sensory function did not get worse.

This is the honest headline. The patch reliably and safely reduces pain for a real share of patients. And it can be repeated about every three months.

Does the capsaicin patch work after one treatment?

One reason patients, and sometimes doctors, give up too soon is that they expect one patch to do everything. The data and clinical experience both suggest the benefit often builds across successive cycles. Each treatment quiets the overfiring fibers again and stretches the window of lower pain. This condition took years to develop. Expecting one application to fix it is not realistic. The protocol is built around repeated, spaced treatments.

Can the capsaicin patch help nerves regrow?

Here is where the science is truly exciting but not yet settled. Capsaicin makes nerve endings pull back and then regenerate. So researchers have asked whether repeated treatment might do more than relieve pain. Might it encourage healthier nerve growth back into the skin? In other words, could it be disease-modifying? A randomized trial in the United Kingdom is formally testing exactly this question in diabetic neuropathy.

Until that kind of study reports, the responsible position is this. The 8% patch is proven for pain relief. Its potential to change the underlying nerve damage is a promising idea under active study. Regenerve’s approach uses the pain-relief window the patch creates as the base for the repair-focused steps that aim at the nerve itself. Those steps are orthobiologics and mitochondrial and metabolic support. As the protocol article covers, those regenerative pieces are themselves emerging and tailored to each person, not guaranteed.

Who is a candidate for the capsaicin 8% patch?

The patch is used for nerve pain in a defined area. Classic uses are the feet for diabetic neuropathy and the affected area for postherpetic neuralgia. Whether it fits you depends on a doctor’s look at where the pain sits, the condition of your skin, and your overall picture. Like any treatment, it works best as part of a plan that also treats the root causes of the neuropathy. It is not a standalone fix.

Frequently asked questions

Key takeaways

• The 8% capsaicin patch is FDA-approved for painful diabetic neuropathy of the feet (2020) and postherpetic neuralgia (2009).
• It works by quieting overfiring TRPV1 pain fibers for a while. It does this without dulling normal feeling and without side effects through the body.
• Trial evidence supports real but modest pain relief. The benefit often builds across repeated treatments.
• Whether it can help nerves regenerate is a fair but still-unproven idea under study.
• It works best inside a plan that also treats the root causes of the neuropathy.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change any treatment without consulting your physician. Take the free Nerve Damage Score or call (314) 886-5739 or text (314) 886-5902.

References

1. Simpson DM, Robinson-Papp J, Van J, et al. Capsaicin 8% patch in painful diabetic peripheral neuropathy: a randomized, double-blind, placebo-controlled study (STEP). J Pain. 2017;18(1):42–53.
2. U.S. FDA. Qutenza (capsaicin) 8% topical system — approval for painful diabetic peripheral neuropathy of the feet. 2020; original PHN approval 2009.
3. Vinik AI, et al. Capsaicin 8% patch repeat treatment plus standard of care in painful diabetic peripheral neuropathy: 52-week open-label safety study (PACE). BMC Neurol. 2016;16:251.
4. Anand P, Bley K. Topical capsaicin for pain management: mechanisms of action of the 8% capsaicin patch. Br J Anaesth. 2011;107(4):490–502.
5. Abrams RMC, et al. A critical review of the capsaicin 8% patch for diabetic peripheral neuropathy of the feet. Expert Rev Neurother. 2021.